Intellectual Property Laws Amendment Act 2015
No. 8, 2015
An Act to amend legislation relating to intellectual property, and for related purposes
Contents
1 Short title
2 Commencement
3 Schedule(s)
Schedule 1—TRIPS Protocol interim waiver
Part 1—Amendments
Patents Act 1990
Part 2—Application
Schedule 2—TRIPS Protocol: later commencing amendments
Patents Act 1990
Schedule 3—Plant Breeder’s Rights Act 1994: Federal Circuit Court
Plant Breeder’s Rights Act 1994
Schedule 4—Australia New Zealand Single Economic Market
Part 1—Amendments
Designs Act 2003
Patents Act 1990
Plant Breeder’s Rights Act 1994
Trade Marks Act 1995
Part 2—Transitional provisions
Schedule 5—Other amendments
Part 1—Document retention
Division 1—Amendments
Designs Act 2003
Patents Act 1990
Trade Marks Act 1995
Division 2—Application of amendments
Part 2—Technical amendments
Division 1—Amendments
Patents Act 1990
Division 2—Application of amendments
Intellectual Property Laws Amendment Act 2015
No. 8, 2015
An Act to amend legislation relating to intellectual property, and for related purposes
[Assented to 25 February 2015]
The Parliament of Australia enacts:
1 Short title
This Act may be cited as the Intellectual Property Laws Amendment Act 2015.
2 Commencement
(1) Each provision of this Act specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provision(s) | Commencement | Date/Details |
1. Sections 1 to 3 and anything in this Act not elsewhere covered by this table | The day this Act receives the Royal Assent. | 25 February 2015 |
2. Schedule 1 | The start of the day after the end of the period of 6 months beginning on the day this Act receives the Royal Assent. | 25 August 2015 |
3. Schedule 2 | The later of: (a) immediately after the start of the day after the end of the period of 6 months beginning on the day this Act receives the Royal Assent; and (b) immediately after Article 31bis of the Agreement on Trade‑Related Aspects of Intellectual Property Rights set out in Annex 1C to the Marrakesh Agreement Establishing the World Trade Organization, done at Marrakesh on 15 April 1994, comes into force for Australia. However, the provision(s) do not commence at all if the event mentioned in paragraph (b) does not occur. The Minister administering the Patents Act 1990 must announce by notice in the Gazette the day the event mentioned in paragraph (b) occurs. | 23 January 2017 (F2017N00010) (paragraph (b) applies) |
4. Schedule 3 | The day after the end of the period of 6 months beginning on the day this Act receives the Royal Assent. | 25 August 2015 |
5. Schedule 4 | A single day to be fixed by Proclamation. However, if the provision(s) do not commence within the period of 24 months beginning on the day this Act receives the Royal Assent, the provision(s) are repealed on the day after the end of that period. | 24 February 2017 (F2016N00044) |
6. Schedule 5, Part 1 | The day after this Act receives… |
Overview
The Intellectual Property Laws Amendment Act 2015 (C2015A00008) was enacted by the Parliament of Australia to amend legislation relating to intellectual property. The primary policy objective of the Act was to implement the World Trade Organization (WTO) General Council decision of 30 August 2003, which aimed to facilitate the availability of medicines to address public health issues, particularly in times of national emergency or other circumstances of extreme urgency. This was achieved through amendments to the Patents Act 1990, enabling the grant of compulsory licences for patented pharmaceutical inventions, allowing for the manufacture and export of pharmaceutical products to eligible importing countries. The Act also made various technical and administrative changes to align with the WTO decision and facilitate smoother implementation across Australia and New Zealand.
Scope and Application
The Intellectual Property Laws Amendment Act 2015 applies to various Acts, including the Patents Act 1990, the Designs Act 2003, the Trade Marks Act 1995, and the Plant Breeder's Rights Act 1994. The Act amends these Acts to implement changes in relation to intellectual property laws, with a specific focus on patents, including the introduction of provisions for compulsory licensing of patented pharmaceutical inventions. It applies to patents and patent applications filed before, on, and after the commencement of the amendments. The Act also extends to New Zealand under the Australia New Zealand Single Economic Market provisions, affecting the practice and procedure of courts in both countries and enabling certain administrative functions to be performed in either jurisdiction. The Act does not explicitly exclude any particular entities or industries from its application, but its provisions are tailored to address specific aspects of intellectual property law. The Act's application may be extended or restricted through subordinate instruments, such as regulations, which can specify details such as notification requirements, the definition of "eligible importing country," and the practice and procedure of courts.
Key Provisions
- The Intellectual Property Laws Amendment Act 2015 amends various pieces of Australian legislation related to intellectual property. The Act introduces new definitions and provisions for compulsory licences in relation to patented pharmaceutical inventions, particularly to address public health issues in eligible importing countries. Key provisions include the ability for the Federal Court to order the grant of a patented pharmaceutical invention compulsory licence (PPI compulsory licence) when the proposed use of the pharmaceutical product is to address a public health issue in an eligible importing country, such as during a national emergency or by public non-commercial use (sections 136B-136C). The Act also details the terms under which such licences can be granted, amended, or revoked (sections 136D-136H). Obligations include the requirement for the applicant to provide statements from the eligible importing country and the importer, and for all parties involved to take reasonable measures to prevent misuse of the pharmaceutical product (section 136D(3)-(4)). The Act imposes specific terms for the licences, such as the quantity of the pharmaceutical product that can be manufactured and exported, and the duration of the licence (section 136F). The Act also outlines the process for determining remuneration for the use of patented pharmaceutical inventions under a PPI compulsory licence (section 136J).
- The Act imposes obligations on various parties, including applicants for PPI compulsory licences, patentees, and eligible importing countries. Applicants must ensure that the proposed use of the pharmaceutical product addresses a public health issue and that they have made a good faith effort to obtain authorisation from the patentee for public non-commercial use if applicable (section 136E(1)(e)-(f)). Patentees are required to be paid an agreed or determined amount of remuneration for the use of their patented pharmaceutical invention (section 136J(1)). Eligible importing countries must take reasonable measures to prevent re-exportation of the pharmaceutical product and provide a statement to this effect (section 136D(3)). The Act also mandates that PPI orders must not be inconsistent with any international agreements and outlines the parties involved in proceedings related to PPI compulsory licences (sections 136K-136M).
- Offences and penalties are not explicitly detailed within the provided text. However, non-compliance with the provisions, such as failure to take required measures to prevent misuse of the pharmaceutical product or not adhering to the terms of the PPI compulsory licence, could potentially lead to legal consequences. For example, the Federal Court may revoke a PPI compulsory licence if certain conditions are not met, such as non-compliance with the terms of the licence (section 136H(2)(b)). The exact penalties for breaches are not specified in the provided text, but they could include civil penalties or other legal actions as determined by the Federal Court.
- Area of Law
- Intellectual Property Law
- Instrument
- Act
- Concepts
- Commencement Provisions
- Definitions & Interpretation
- Licensing & Registration
- Enforcement Powers
- Regulatory Standards
- Offence Provisions